Author:
Lawal I. O.,Sathekge Mike
Publisher
Springer International Publishing
Reference51 articles.
1. Wu S, Zhang Y, Sun F, Chen M, Zhou L, Wang N, et al. Adverse events associated with the treatment of multi-drug-resistant tuberculosis: a systematic review and meta-analysis. Am J Ther. 2016;23(2):e521–30.
2. Senousy BE, Belal SI, Draganov PV. Hepatotoxic effects of therapies for tuberculosis. Nat Rev Gastroenterol Hepatol. 2010;7(10):543–56.
3. Krasniqi S, Jakupi A, Daci A, Tigani B, Jupoli-Krasniqi N, Pira M, et al. Tuberculosis treatment adherence of patients in Kosovo. Tuberc Res Treat. 2017;2017:4850324.
4. Ukwaja KN, Alobu I, Lgwenyi C, Hopewell PC. The high cost of free tuberculosis services: patient and household costs associated with tuberculosis care in Ebonyi State, Nigeria. PLoS One. 2013;8(8):e73134.
5. Pooran A, Pieterson E, Davids M, Theron G, Dheda K. What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PLoS One. 2013;8(1):e54587.